IntoCell Inc
KOSDAQ:287840
तय करें कि किस कीमत पर खरीदना आपके लिए उचित होगा। तैयार रहने में हम आपकी मदद करेंगे।
|
I
|
IntoCell Inc
KOSDAQ:287840
|
KR |
|
P
|
Paychex Inc
DUS:PCX
|
US |
|
Roctool SA
PAR:ALROC
|
FR |
|
P
|
Progressive Corp
F:PGV
|
US |
|
T
|
Total Soft Bank Ltd
KOSDAQ:045340
|
KR |
|
Sampo Oyj
F:SMP2
|
FI |
|
C
|
Capital One Financial Corp
F:CFX
|
US |
|
C
|
Capital One Financial Corp
XMUN:CFX
|
US |
|
S
|
Salazar Resources Ltd
XMUN:CCG
|
CA |
|
P
|
Primex Corp
XPHS:PRMX
|
PH |
|
Goldn Futures Mineral Corp (Pre-Reincorporation)
OTC:GFTRF
|
CA |
|
V
|
Vienna Insurance Group Wiener Versicherung Gruppe AG
XMUN:WSV2
|
AT |
|
A
|
Altius Minerals Corp (AB)
DUS:VTM
|
CA |
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
|
Techtronic Industries Co Ltd
F:TIB
|
HK |
|
S
|
Security Bank Corp
XPHS:SECB
|
PH |
|
Bank Permata Tbk PT
F:85C
|
ID |
|
J
|
Jyske Bank A/S
F:JYS1
|
DK |
|
G
|
George Weston Ltd
OTC:WNGRF
|
CA |
|
Q
|
Qualcomm Inc
BMV:QCOM
|
US |
|
Paterson Resources Ltd
ASX:PSL
|
AU |
|
First BanCorp
F:OLWN
|
PR |
|
Eurocommercial Properties NV
F:N4SA
|
NL |
|
Ovation Science Inc
F:0VH
|
CA |
आंतरिक मूल्य
IntoCell Inc का आंतरिक मूल्य भरोसेमंद ढंग से निकालने के लिए पर्याप्त डेटा नहीं है।
क्या हमारे मूल्यांकन वास्तव में कारगर हैं? बैकटेस्ट के परिणाम देखें .
मौलिक विश्लेषण
IntoCell क्या करती है
IntoCell, Inc. engages in the research and development of ADC platform technology. The company is headquartered in Daejeon, Daejeon and currently employs 43 full-time employees. The company went IPO on 2025-05-23. The firm mainly develops ortho-hydroxy-protected aryl sulfate (OHPAS) platform technology, which is a linker connecting to drugs. In addition, the Company also develops platform technologies such as payload modification technology (PMT) platform technology, which reduces drug uptake into normal cells, and proprietary drug technology used in ADC development.
- मुख्यालय
- कोरिया KR
- कर्मचारी
- 43
- IPO की तारीख
- मई 23, 2025
